SARMISTHA BHALLA: Open Payments
NPI 1083791792 · MEXICO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 10 payments from 6 companies in 2025. Trend: 2023 $574 · 2024 $287 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
Products named: INGREZZA, ABILIFY ASIMTUFII, UZEDY, REXULTI, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA.
Industry payments across MO — which companies pay providers there.
